• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 77 of 100
Senate Permanent Subcommittee On Investigations Hearing On U.S. Corporate Tax Code
HealthSenate Calls for Former Valeant CFO to Testify at Hearing
By Laura LorenzettiApril 26, 2016
Businessman with Duchenne muscular dystrophy in a motorized wheelchair working in an office
HealthThis Rare Children’s Disease Drug Is Pitting Patients Against the FDA
By Sy MukherjeeApril 26, 2016
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
HealthValeant Has Named Joseph Papa its New CEO
By ReutersApril 25, 2016
Novartis AG Full Year Results News Conference
FinanceNovartis May Sell Its $14 Billion Stake in Roche to Fuel Acquisitions
By ReutersApril 25, 2016
Apple Starts iPhone 6 Sales In Germany
TechU.S. Drops N.Y. Fight with Apple After Gaining Access to iPhone
By ReutersApril 23, 2016
Venter
HealthAstraZeneca Is Launching a Massive Gene Hunt With This Genome Pioneer
By ReutersApril 22, 2016
Perrigo CEO Joe Papa, right, at a charity event in 2013.
LeadershipValeant Reportedly Wants This Guy as its New CEO
By ReutersApril 22, 2016
This Is the Best Drugstore Stock to Own Now
FinanceThis Is the Best Drugstore Stock to Own Now
By Chris TaylorApril 20, 2016
The Two Mercks Are Locking Horns in a Naming Trademark Spat
HealthThe Two Mercks Are Locking Horns in a Naming Trademark Spat
By Sy MukherjeeApril 18, 2016
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
FinanceAstraZeneca Is Eyeing This San Francisco Drugmaker
By ReutersApril 18, 2016
Apple Again Pushes Back Against Unlocking iPhone in New York Drug Case
TechApple Again Pushes Back Against Unlocking iPhone in New York Drug Case
By ReutersApril 15, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceValeant Talking to Investment Banks to Weigh Asset Sales
By ReutersApril 15, 2016
Inside of a Gilead Sciences Lab
HealthThe FDA Wants Pharma to Ditch its Archaic Drug Making Process
By Sy MukherjeeApril 14, 2016
Controversial Former Pharmaceutical CEO Martin Shkreli Testifies On Oversight In Drug Market
HealthU.S. Drug Spending Hits Record High (Again)
By Erika FryApril 14, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
HealthValeant’s CEO Just Avoided Contempt Charges From the U.S. Senate
By ReutersApril 13, 2016
1...
  • 75
  • 76
  • 77
  • 78
  • 79
...100
Most Popular
Future of Work
'Employers are increasingly turning to degree and GPA' in hiring: Recruiters retreat from ‘talent is everywhere,’ double down on top collegesplaceholder alt text
By Jake AngeloMay 9, 2026
Politics
Ted Cruz says the quiet part out loud: Trump accounts are Social Security personal accounts as GOP senator reveals 'dirty little secret'placeholder alt text
By Jason MaMay 9, 2026
Economy
‘This is the way’: Elon Musk endorses Warren Buffett’s famed 5-minute plan to fix the national debtplaceholder alt text
By Jacqueline MunisMay 10, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.